US Patent Family Members and Approved Drugs for South Africa Patent: 9208296
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for South Africa Patent: ZA9208296
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| ⤷ Start Trial | 2014-08-05 | alemtuzumab | Genzyme Corporation | CAMPATH |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
